Simplex Trading
TTPH

Simplex Trading’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Simplex Trading’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-671
Closed -$17.1K – 8235
2018
Q4 		$15K Sell
671
-1,549
-70% -$60.6K ﹤0.01% 5594
2018
Q3 		$122K Buy
+2,220
New +$142K ﹤0.01% 4229
2018
Q2 		– Sell
-1,541
Closed -$109K – 8155
2018
Q1 		$94K Sell
1,541
-189
-11% -$16.6K ﹤0.01% 1856
2017
Q4 		$217K Buy
+1,730
New +$222K 0.01% 1216
2017
Q1 		– Sell
-89
Closed -$9.98K – 7095
2016
Q4 		$7K Buy
+89
New +$7.04K ﹤0.01% 4123
2016
Q3 		– Sell
-146
Closed -$11.7K – 6780
2016
Q2 		$12K Sell
146
-533
-78% -$48.8K ﹤0.01% 3459
2016
Q1 		$62K Buy
+679
New +$67.8K ﹤0.01% 1770
2015
Q4 		– Sell
-4,162
Closed -$830K – 6461
2015
Q3 		$620K Buy
4,162
+3,724
+850% +$2.73M 0.05% 375
2015
Q2 		$416K Buy
438
+211
+93% +$173K 0.03% 455
2015
Q1 		$166K Buy
227
+1
+0.4% +$751 0.02% 806
2014
Q4 		$180K Buy
+226
New +$122K 0.02% 648

Other funds holding TTPH

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Simplex Trading's TTPH Position: Q1 2019 in Review

Simplex Trading sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q1 2019, closing a stake of 671 shares — an estimated $17.1K sold.

Simplex Trading first reported a position in TTPH in Q4 2014 and held it in 11 quarters. The position peaked at $620K in Q3 2015. 78 funds tracked by Wall St. Rank hold TTPH as of Q1 2019.

  • Simplex Trading reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q1 2019 after selling out during the quarter.
  • Simplex Trading sold 671 Tetraphase Pharmaceuticals, Inc. shares in Q1 2019, an estimated $17.1K.
  • Simplex Trading first reported a position in Tetraphase Pharmaceuticals, Inc. in Q4 2014 and held it in 11 quarters.
  • Simplex Trading's Tetraphase Pharmaceuticals, Inc. position peaked at $620K in Q3 2015.
  • 78 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q1 2019.

Based on Simplex Trading's 13F filing for Q1 2019, filed 18 Apr 2019.